Importantly, the absence of transfusions occurred within a patient blood-management framework that triggers transfusion only at Hb < 8 g/dL or in symptomatic anemia, reinforcing the clinical irrelevance of the small adjusted differences in early Hb decline. This evidence concerns the gene GSTM1 and anemia (phenotype).